What does the evidence say about Omega-3?

The current Migaku evidence database contains 3 reusable source documents for Omega-3. This answer focuses on benefits, uncertainty, and practical interpretation. - Efficacy of phospholipid-bound omega-3 versus standard omega-3 in patients with hypertriglyceridemia: a randomized clinical trial. [Urina-Triana M (2026); evidence level 2] - 9 10 Given the modest efficacy of standard interventions, interest in well-tolerated, low-risk alternatives is increasing (). [Fleig Katharina (2026); evidence level 3] - Conversely, omega-3 PUFAs eicosapentaenoic acid (EPA; 20:5ω3), docosapentaenoic acid (DPA; 22:5ω3), and docosahexaenoic acid (DHA; 22:6ω3) are predominantly found in fatty marine fish and algae (,). [Fleig Katharina (2026); evidence level 3] - Evidence suggests that ALA may have a neuroprotective and anti-inflammatory potential concerning systemic, neuroinflammatory, and mental disorders (). [Fleig Katharina (2026); evidence level 3] - 1 2 3 5 5 Mental disorders currently rank among the leading contributors to the global burden of disease, posing substantial individual and societal challenges (,). [Fleig Katharina (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.